Please check for more information about device compatibility before using the app. § The LibreLinkUp app is only compatible with certain mobile device and operating systems. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice. ₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. You do not need to be connected to check your glucose, receive alarms, add notes or review your history in the App. * You need to be connected to a network for setup, using LibreView and sharing with other apps. Sharing of glucose data requires registration with LibreView. Please check our website for more information about device compatibility before using the app. ◊ The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. ₸ Sensor is water resistant in up to 1 metre (3 feet) of water for a maximum of 30 minutes. For use of FreeStyle Libre 3 sensor with the mylife Loop, refer to the labeling provided with the mylife CamAPS FX app. ^ FreeStyle Libre 3 is authorised to work with the mylife Loop automated insulin delivery system, including the mylife CamAPS FX app and mylife YpsoPump insulin pump. Only use hybrid closed loop systems if the person or their carer understands and is able to use them, and is also attending a type 1 diabetes structured education programme. Only use hybrid closed loop systems with the support of a trained multidisciplinary team experienced in continuous subcutaneous insulin infusion and continuous glucose monitoring in type 1 diabetes. NICE Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. An HCL system consists of a continuous glucose monitor (CGM) sensor, a control algorithm and an insulin pump.ħ. Data on file, Abbott Diabetes Care, Inc.Ħ. "The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: a Meta-analysis of Clinical Trials and Real-world Observational Studies." Diabetes Therapy 11, no. “Novel Glucose-Sensing Technology and Hypoglycaemia in Type 1 Diabetes: a Multicentre, Non-Masked, Randomised Controlled Trial.” Lancet 388, no. Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestjin, Jens Kröger, Raimund Weitgasser. Journal of Diabetes Science and Technology.ģ. “Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System with Advanced Algorithm in Pediatric and Adult Population With Diabetes.”. Christiansen, Gregory Forlenza, Mark Kipnes, David R. Not real patient or data.ġ. Among patient-applied glucose sensors. Data on file, Abbott Diabetes Care, Inc.Ģ. Shridhara Alva, Timothy Bailey, Ronald Brazg, Erwin S. Images are for illustrative purposes only.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |